Procaps Group, S.A.

3.45 USD
+0.56 (+19.38%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Procaps Group, S.A. stock is down -7.01% since 30 days ago. The next earnings date is May 10, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 March’s closed higher than February.

About Procaps Group, S.A.

Procaps Group, S.A. operates as an integrated healthcare and pharmaceutical company worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products.